Cargando…
Ischemic preconditioning protects the heart against ischemia-reperfusion injury in chronic kidney disease in both males and females
BACKGROUND: Uremic cardiomyopathy is a common cardiovascular complication of chronic kidney disease (CKD) characterized by left ventricular hypertrophy (LVH) and fibrosis enhancing the susceptibility of the heart to acute myocardial infarction. In the early stages of CKD, approximately 60% of patien...
Autores principales: | Sárközy, Márta, Márványkövi, Fanni Magdolna, Szűcs, Gergő, Kovács, Zsuzsanna Z. A., Szabó, Márton R., Gáspár, Renáta, Siska, Andrea, Kővári, Bence, Cserni, Gábor, Földesi, Imre, Csont, Tamás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420010/ https://www.ncbi.nlm.nih.gov/pubmed/34488888 http://dx.doi.org/10.1186/s13293-021-00392-1 |
Ejemplares similares
-
Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy
por: Kovács, Zsuzsanna Z. A., et al.
Publicado: (2021) -
Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212
por: Sárközy, Márta, et al.
Publicado: (2019) -
Investigation of the Antihypertrophic and Antifibrotic Effects of Losartan in a Rat Model of Radiation-Induced Heart Disease
por: Kovács, Mónika Gabriella, et al.
Publicado: (2021) -
Neuregulin-1β Improves Uremic Cardiomyopathy and Renal Dysfunction in Rats
por: Sárközy, Márta, et al.
Publicado: (2023) -
Investigation of the Antiremodeling Effects of Losartan, Mirabegron and Their Combination on the Development of Doxorubicin-Induced Chronic Cardiotoxicity in a Rat Model
por: Freiwan, Marah, et al.
Publicado: (2022)